First Description of a TEM-30 (IRT-2)-Producing Klebsiella oxytoca Isolate
Open Access
- 1 April 2002
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (4) , 1158-1159
- https://doi.org/10.1128/aac.46.4.1158-1159.2002
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Updated Sequence Information and Proposed Nomenclature for bla TEM Genes and Their PromotersAntimicrobial Agents and Chemotherapy, 2000
- Screening and confirmatory testing for extended spectrum β-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca clinical isolates☆Diagnostic Microbiology and Infectious Disease, 2000
- Molecular Characterization of TEM-59 (IRT-17), a Novel Inhibitor-Resistant TEM-Derived β-Lactamase in a Clinical Isolate of Klebsiella oxytocaAntimicrobial Agents and Chemotherapy, 1999
- Inhibitor-Resistant OXY-2-Derived β-Lactamase Produced by Klebsiella oxytocaAntimicrobial Agents and Chemotherapy, 1998
- Discriminatory Detection of Inhibitor-Resistant β-Lactamases in Escherichia coli by Single-Strand Conformation Polymorphism-PCRAntimicrobial Agents and Chemotherapy, 1998
- Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytocaAntimicrobial Agents and Chemotherapy, 1995
- A survey of β-lactamases from 618 isolates of Klebsiella sppJournal of Antimicrobial Chemotherapy, 1993
- Incompatibility groups and the classification of fi - resistance factors.1972
- Incompatibility Groups and the Classification of fi − Resistance FactorsJournal of Bacteriology, 1972